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Hormonal effects of short-term administration of an analgesic,
clometacin.A. Baumelou, G. Deray, A. Hornych, R. Brouard, G. Fredj,
H. Merdjan, and F. de Groc. Service de Néphrologie, Hdpital de Ia
Pitie; U. 28 de l'INSERM. HópilalBroussais; and Pharmacie Centrale,
Hôpital de la PitiE, Paris, France. Clometacin is an analgesic com-
pound widely used in France and many African countries. A few cases
of acute renal failure have been reported with this drug during the last
3 years. The physiopathology of these events remains unclear. To
determine whether these deleterious effects on renal function could be
similar to those observed with nonsteroidal anti-inflammatory drugs
(NSAID) the following protocol was performed in six healthy well
informed volunteers after written consent: 150 mg of clometacine were
administered three times a day during 4 days after a control period of 3
days. All subjects were on a normal free diet with sodium and water ad
libitum both during the control period and while receiving the drug.
During drug administration there is no significant change in mean supine
blood pressure, heart rate, body weight urinary flow rate, urinary
sodium and potassium excretion, or endogenous creatinine clearance.
Urinary excretion of prostaglandins (PGs) PGE,, 6 keto PGF1 alpha,
TxB2, and PGF2 alpha are drastically reduced by 41.2, 61.2, 59, and
35.3%, respectively (P < 0.05 for all the compounds). Concomitantly,
there is a 62% reduction of upright plasma renin activity (PRA).
Furthermore, there is a very close correlation between the fall (ex-
pressed as percentage of the basal level) of the PRA and the urinary
excretion of TxB2 (r = 0.86, P <0.05). No such correlation is observed
with the other POs. Three main conclusions can be drawn from these
results: first, clometacin, an analgesic compound with mild anti-
inflammatory pharmacological effects, has the same effect on PRA and
urinary PGs as practically all other nonsteroidal anti-inflammatory
drugs. Such an action can explain, in some hyperadrenergic conditions,
the deleterious renal effects reported with the drug. No effect on
glomerular filtration rate and water and electrolyte balance was ob-
served in healthy subjects on a free sodium and water intake. During
short-term administration of this drug, we found for the first time a very
close correlation between urinary excretion of TxB2 and PRA, suggest-
ing that TxA2 can also play an important role in the regulation of renin
release.
Right-sided hydrothorax during peritoneal dialysis: Frequency and
outcome. B. Branger, R. Oules, G. Deschodt, J. P. Balducchi, A.
Slingeneyer, J. Fourcade, and C. Mion. Ncphrology Department,
C.H.R.U. NImes, France. Occurrence of acute hydrothorax during
peritoneal dialysis (PD) has been infrequently reported and no data are
available on the frequency of this complication. We reported two cases:
the first occurred in a 64-yr-old female with polycystic kidney and liver
disease with ESRD indicating PD with the implantation of an Ash
catheter. No trouble occurred during the postoperative period and
training was undertaken for CAPD education. Six months later, she
presented an acute and severe dyspnea with intense right thoracic pain,
pleural effusion was clinically evident and required puncture:
Hydrothorax composition was: total protein 0.1 g/dl, glucose 8.9
mmoles/liter compared to plasma values: protein 5.7 g/dl, glucose 3.7
mmoles/liter. Hydrothorax recurred within 1 hr after each further PD
attempt and the patient was hemodialyzed for 4 weeks, when CAPD
was reintroduced without any problem. The second case occurred in a
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55-year-old woman, also with polycystic kidney and liver disease. She
also presented right rib callus secondary to a fall 5 years earlier and a
left sided hemiplegia. Tenckhoff catheter was implanted but PD was
poorly successful with a long draining time. Immediately after the first
CAPD bag infusion, she suffered thoracic pain and severe dyspnea.
Right hydrothorax was present with the following composition: protein
0.9 g/dt, glucose 6.7 mmoles/titer compared to plasma value: 5.2 g/dl
and 4 mmoles/liter. Hydrothorax recurred at each PD attempt (neither
IPD nor CAPD) so definitive transfer to HD was decided; unfortunately
neurological status worsened and the patient died 4 months later. From
March 1977 to December 1983, 110 ESRF patients have been initiated
to PD (112 Tenckhoff catheter, 14 Ash catheter). During these 5 years,
incidence of right hydrothorax have been 1.8% (0.3% per year). From
the literature and our experience, we confirm the female prevalence
(five females for one male). PD catheter or nephropathy are not
regarded as a possible cause but we underline in the second patient the
rib fractures which could have induced diaphragm perforation. Out-
come of this complication can be summarized by our observations: (I)
in most of the cases reported in the literature (10 of 19) PD is still
possible after transient transfer to IPD or HD for 3 to 4 weeks; (2) in the
other patients (9 of 19), transfer to HD is definitive and in these patients
hydrothorax often occurs within I day after catheter implantation (6 of
7 patients reported) suggesting two different mechanisms: in patient 1,
transient diaphragm relaxation and tissue permeability enhancement
can be involved; in patient 2, permanent congenital or acquired pleu-
roperitoneal fistula definitively contraindicates PD.
Hormonal modulation with danazol and cyproterone acetate in systemic
lupus erythematosus (SLE): A preliminary open trial. P. Jun gers, M.
Dougados, C. Pélissier, N. Athéc, F. Lioté, M. C. Laurent, and F.
Kuttenn. Departments of Nephrology and Reproductive Endocrinol-
ogy, Necker Hospital, Paris, France. In view of the beneficial effects of
androgens and unfavorable effects of estrogens in experimental lupus
disease, we prospectively evaluated clinical efficacy and tolerance of
two antigonadotropic drugs, danazol (D) and cyproterone acetate (CA)
in 11 female patients (mean age: 37.4 yr, range 19 to 47) with moderately
active SLE. Of them, eight initially had severe forms of SLE (with
diffuse proliferative glomerulonephritis in five) and were previously
treated with high-dose corticosteroid (CS) therapy. D was used in six
patients and had to be discontinued in two (because of rash and rise in
liver enzymes in one, of myalgias in the other who was shifted to CA).
CA was used in six courses without reported side effects. Duration of
hormonal treatment ranged from 12 to 27 months in ten courses. When
compared to the 12-month pretreatment period, incidence of lupus
flare-ups decreased from 19 to 8 during the corresponding 12-month
treatment period (P < 0.02, Wilcoxon test). Maintenance dose of
prednisone (mean SEM) was reduced from 9.8 3.2 to 4.5 2.6
mg/day (P < 0.02). Clinical improvement was especially marked in
three patients with mouth ulcers (one with D, two with CA). Both drugs
induced a modification of the hormonal milieu toward a higher
androgen/estrogen balance, as reflected by a decrease in the plasma
level of the sex hormone binding protein. A rise in plasma testosterone
with unchanged plasma estradiol was observed with D, whereas a
marked decrease in plasma estradiol with unchanged plasma
testosterone was observed with CA. We conclude that hormonal
modulation using CA and D may be of therapeutic interest in female
patients with moderately active SLE, allowing lower doses of CS to
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control disease activity. Both drugs were of similar clinical activity but
tolerance of CA was better.
Food allergy and idiopathic nephrotic syndrome (INS). G. Lagrue, J.
Laurent, D. Beighiti; and J. Sainte-Laudy. Hópital Henri Mondor,
Créteil, France. The role of allergy in INS (minimal changes in optical
microscopy and negative immunofluorescence) is well documented by
clinical and biological data. Among environmental allergens, pneumal-
lergens have been involved in most reported cases. Common food
allergens may also be implicated as demonstrated previously. Never-
theless, their responsibility is not usually sought. We have systemically
investigated 25 INS for sensitization against five common food al-
lërgens: cow's milk, egg, beef, pork, and flour. (1) Skin tests and
specific IgE (RAST) were seldom positive and most often not indica-
tive; (2) Human Basophil Degranulation Test (HBDT) was positive in 17
patients for at least one food: cow's milk, five; whole egg, four; beef,
four; pork, six; and flour, seven. Tn 20 blood donors (paired for sex and
age), an HBDT positive test was observed only once (to flour); (3)
specific IgG 4 against these foods were also present in 16 out of 22
patients with poor correlation between HBDT and lgG-4 results. The
responsibility of these food allergen(s) was investigated by exclusion
and reintroduction tests in 16 cases, with significant variations of
proteinuria/24 hr (> 50%) in four patients. Several foods were most
often involved. In eight cases, oral cromoglycate was administered as a
therapeutic test (300 mg before each meal) with positive results in two.
Allergy to food may be responsible for INS; the real frequency of this
etiology is still unknown.
Idiopathic and recurrent extracapillary glomerulonephritis: Favorable
evolution with treatment. J. N. Ottavioli, P. Birembaut, M. Fakir, K.
Rebaiz, and C. Wolfe. Service de Médecine D, Hôpital Manchester
Charleville Mezieres, and Laboratoire Pol Bouin Hôpital Maison
Blanche, Reims, France. During the last few years, extracapillary
glomerulonephritis (ECGN) has been better treated with the combined
utilization of corticosteroids and plasma exchange (PE). Nevertheless,
reports of long follow-up and recurrences are rare in the literature. We
present the case of an idiopathic ECGN in a 44-year-old patient with a
recurrence after 1 year of therapeutic remission. This ECGN was
characterized by an acute renal failure (serum creatinifle, 220
Umoles/liter), absence of anti-GBM antibodies, presence of circulating
immune complexes and an extracapillary proliferation involving 90% of
the glomeruli examined on the first renal biopsy. There were no immune
deposits in immunofluorescence. The treatment combined the use of
corticosteroids, cyclophosphamide and PE (12 sessions with
plasmafiltration) and provided complete functional recovery with his-
tologic regression of the lesions. During follow-up clinical and his-
tologic recurrence appeared. A new therapeutic protocol analogous to
the first treatment but with nine PE sessions (with centrifugation) led to
a new recovery (serum creatinine decreasing from 454 to 110
Umoles/liter). However, histologic examination revealed an increase of
fibrosis in glomeruli and interstitium. This observation, compared to the
data of the literature, shows that the natural outcome of idiopathic
ECGN is changed by this treatment. The possibility of recurrences,
recently described, justifies strict and continued surveillance after
remission. Their frequency and subsequent functional effects remain to
be defined by further studies.
